They found that various ovarian cancer cell lines treated with cisplatin or carboplatin induced differentiation of macrophages into an M2-like phenotype characterized by elevated production of IL-10 and enhanced activation of STAT3 signaling factor. The gene discussed is IL10; the disease is ovarian carcinoma.